Uniting biological toolkits for a new approach to ALS

Co-Scientist is facilitating a collaboration between Boston Children’s Hospital and MIT to investigate novel RNA-based therapies for Amyotrophic Lateral Sclerosis (ALS). This initiative aims to develop new treatment approaches by combining their biological toolkits.